Confirmation of Exclusive License Agreement between Cedars-Sinai Medical Center and Arrogene NanoTechnology, Inc.

Contract Categories: Intellectual Property › License Agreements
Summary

Cedars-Sinai Medical Center confirms that its Exclusive License Agreement with Arrogene NanoTechnology, Inc., originally dated December 23, 2009, remains valid and in effect as of March 9, 2012. This letter serves as official written confirmation to Arrogene NanoTechnology, Inc. that the terms of the license agreement continue to apply. No changes or additional obligations are specified in this confirmation.

Read More Arrow
EX-10.21 2 cedarlicenseltr.htm CONFIRMATION OF CSMC LICENSE Converted by EDGARwiz

CEDAR-SINAI MEDICAL CENTER

Academic Affairs



Richard S. Katzman

Vice President, Academic Affairs


March 9, 2012


VIA EMAIL

Arrogene NanoTechnology, Inc.

5777 West Century Blvd., Suite 360B

Los Angeles, CA  90045

Attention:  Maurizio Vecchione


Re:  Exclusive License Agreement dated December 23, 2009 between Arrogene NanoTechnology, Inc. and Cedars-Sinai Medical Center (“License Agreement”)


Dear Mr. Vecchione:


This letter will serve to confirm that Cedars-Sinai Medical Center deems the above-referenced License Agreement to be in full force and effect as of the date hereof.


Sincerely Yours,


CEDARS-SINAI MEDICAL CENTER


/s/ Richard S. Katzman

Richard S. Katzman

Vice President, Academic Affairs



Enclosure


cc:

James D. Laur, Esq. (via email)